Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5QYT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,254
Award facts
- Contract value 100% obligated
- $37,253.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $37,253.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen (2 ml) on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside award was competitively procured and performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc., which holds a significant $999.99 billion indefinite delivery contract with DLA Troop Support Medical through December 2031, serving as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Dupixent (dupilumab) is a prescription biologic medication used to treat various inflammatory conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order represents a routine pharmaceutical replenishment supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems within the military supply chain. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates the company's established capability to fulfill critical medical supply needs for the Department of Defense medical system, with contract awards consistently structured as firm fixed-price transactions across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5QYT?
SPE2DR26F5QYT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F5QYT worth?
The government has obligated $37,254 on SPE2DR26F5QYT.
Is contract SPE2DR26F5QYT an order under another contract?
Yes. SPE2DR26F5QYT is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QYT competed?
The extent of competition for SPE2DR26F5QYT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award